Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Quoin Pharmaceuticals Ltd. ADR

Start price
Target price
Perf. (%)
€3.06
03.09.22
-
03.09.23
-86.05%
24.04.23

Risky Investment
Lokrim 
03.09.22 20%
buy
Invitae Corp

Start price
Target price
Perf. (%)
€2.76
02.09.22
-
02.09.23
-10.51%
27.09.22

Could be very worthwhile Investment >20% year
Wolf_of_WS 
02.09.22 50%
sell
Abivax S.A.

Start price
Target price
Perf. (%)
€8.30
02.09.22
€5.00
31.12.24
85.30%
08.05.23

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
02.09.22 70%
sell
Nuwellis Inc.

Start price
Target price
Perf. (%)
€1.69
31.08.22
-
31.08.23
-93.25%
18.05.23

Could be very worthwhile Investment >20% year
quelbe60 
31.08.22 50%
sell
Nuwellis Inc.

Start price
Target price
Perf. (%)
€1.26
31.08.22
-
31.08.23
-90.95%
29.05.23

Could be very worthwhile Investment >20% year
blaugold 
31.08.22 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€14.42
29.08.22
-
29.08.23
-59.22%
19.05.23

Could be very worthwhile Investment >20% year
Global_Player 
29.08.22 50%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.61
29.08.22
-
29.08.23
-10.43%
15.10.22

Could be very worthwhile Investment >20% year
Wolf_of_WS 
29.08.22 50%
sell
Novavax Inc.

Start price
Target price
Perf. (%)
€34.98
27.08.22
€16.00
27.08.23
-38.94%
13.10.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
geldnutzer 
27.08.22 50%
buy
Tonix Pharmaceuticals Holding Corp.

Start price
Target price
Perf. (%)
€7.13
26.08.22
-
26.08.23
-14.99%
03.09.22

Probably not worthwhile Investment
bundfuture 
26.08.22 50%
buy
Invitae Corp

Start price
Target price
Perf. (%)
€3.32
26.08.22
-
26.08.23
-17.03%
03.09.22

Could be very worthwhile Investment >20% year
Global_Player 
26.08.22 50%
buy
Daiichi Sankyo Co Ltd

Start price
Target price
Perf. (%)
€31.05
25.08.22
-
25.08.23
-14.11%
26.08.23

Could be worthwhile Investment >10% per year
melinda 
25.08.22 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.85
24.08.22
-
24.08.23
-10.03%
03.09.22

Could be worthwhile Investment >10% per year
Vassago1 
24.08.22 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€90.50
24.08.22
€120.00
24.08.23
17.79%
08.05.23

Could be worthwhile Investment >10% per year
IfYouCanDreamItYouCanDoIt 
24.08.22 70%
buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€5.40
23.08.22
-
23.08.23
29.96%
09.09.22

Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
efeu 
23.08.22 50%
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€65.38
23.08.22
-
23.08.23
6.12%
23.08.23

Saftman 
23.08.22 50%
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€36.50
22.08.22
€66.00
22.08.23
-8.22%
03.09.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
kostojunior 
22.08.22 80%
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€25.58
22.08.22
€44.00
22.08.23
-5.00%
03.09.22

Could be very worthwhile Investment >20% year
Capable Management
Good culture
Innovative
kostojunior 
22.08.22 70%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€64.74
22.08.22
€80.00
22.08.23
8.80%
23.08.23

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
bullbear 
22.08.22 90%
buy
Mediwound Ltd.

Start price
Target price
Perf. (%)
€1.99
22.08.22
-
22.08.23
-7.04%
04.09.22

Could be very worthwhile Investment >20% year
quelbe60 
22.08.22 50%
buy
Mediwound Ltd.

Start price
Target price
Perf. (%)
€1.99
22.08.22
€4.00
22.08.23
-7.04%
04.09.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Marianka 
22.08.22 50%
buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€76.50
21.08.22
€230.00
21.08.23
6.54%
04.09.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Ruckelsbuckel 
21.08.22 50%
sell
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€214.90
21.08.22
€87.00
21.08.23
-3.44%
04.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
dimontalban 
21.08.22 60%
sell
Invitae Corp

Start price
Target price
Perf. (%)
€3.50
21.08.22
€1.00
21.08.23
-21.28%
04.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
dimontalban 
21.08.22 50%
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€2.49
20.08.22
-
20.08.23
-75.54%
07.06.23

Could be worthwhile Investment >10% per year
melinda 
20.08.22 40%
sell
Mediwound Ltd.

Start price
Target price
Perf. (%)
€2.00
19.08.22
-
19.08.23
470.00%
08.01.23

Risky Investment
bundfuture 
19.08.22 50%